Últimos Artículos de Diabetes, Obesity and Metabolism
- Oral TIX100 protects against obesity‐associated glucose intolerance and diet‐induced adiposity
- Fibroblast growth factor 23 predicts incident diabetic kidney disease: A 4.6‐year prospective study
- Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high‐dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia
- Short‐term outcomes of switching from GLP‐1 receptor agonists to tirzepatide in type 2 diabetes: A retrospective, observational study in clinical practice
- Long‐term use of Minimed™ 780G in children and adolescents with type 1 diabetes under real‐world conditions: The benefits of optimal settings
- Recognition of ophthalmology consultation and fundus examination among individuals with diabetes in Japan: A cross‐sectional study using claims‐questionnaire linked data
- Diabetes and incident stroke and mediation by microvascular dysfunction: Pooled analysis of three population‐based studies
- Targeted metabolomics reveals novel biomarkers for gestational diabetes mellitus
- Clinical effectiveness and cost‐effectiveness of first‐line early combination of dipeptidyl peptidase 4 inhibitors and metformin in patients with type 2 diabetes in Taiwan: A modelling study
- The physiological impact of an N‐terminal Halo‐tag on glucose‐dependent insulinotropic polypeptide receptor function in mice
- Comparative effectiveness of insulin glargine, glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter‐2 inhibitors in veterans with type 2 diabetes
- Actual weight loss trajectories after bariatric surgery compared with the SOPHIA prediction tool: An observational comparison study
- Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review
- Impact of time in tight range on all‐cause and cardiovascular mortality in type 2 diabetes: A prospective cohort study
- Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
- Evaluation of the analytical and clinical accuracy of four blood glucose meters in pregnant women with hyperglycaemia
- Follistatins, activins and inhibins during osteoporosis therapy with denosumab or zoledronate and after their discontinuation
- Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon‐like peptide‐1 receptor agonist therapy in UK primary care: A retrospective, real‐world study
- The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP‐1/GIP receptor agonist (BGM0504) in healthy volunteers: A dose‐escalation Phase I study
- Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real‐world evidence from a 22‐year follow‐up study